Eike Joest

Principal Scientist for mRNA Innovation

Eike is Principal Scientist for innovations and technologies in mRNA service offering. He was responsible for development of the upscaled mRNA manufacturing process and implementation of AmpTec™ technologies in R&D.
Before joining

Merck KGaA in Darmstadt, Germany
, he demonstrated broad technical expertise in synthetic biology and molecular biology by publishing in several peer-reviewed journals. Eike holds a M.Sc. with distinction in Biochemistry from Wuerzburg University and a summa cum laude Ph.D. in cellular Biochemistry from Frankfurt University.

Key Benefits of PCR-based mRNA manufacturing for clinical development

mRNA technology offers many opportunities but the development and manufacturing of mRNA-based vaccines and therapeutics present a number of challenges. Learn more about the opportunities of the mRNA technology and how to overcome drug development and manufacturing challenges to bring your mRNA-based therapies to market in this first webinar.

Scroll to Top